Indian pharmaceutical firm Gennova Biopharmaceuticals' mRNA-based COVID-19 vaccine was found to be safe and effective in an early-stage study, the country's drug regulator said on Tuesday.

Health authorities have allowed the company to conduct further studies to test the vaccine's efficacy.

Leave a Reply

Your email address will not be published. Required fields are marked *

Indian pharmaceutical firm Gennova Biopharmaceuticals' mRNA-based COVID-19 vaccine was found to be safe and effective in an early-stage study, the country's drug regulator said on Tuesday.

Health authorities have allowed the company to conduct further studies to test the vaccine's efficacy.

Leave a Reply

Your email address will not be published. Required fields are marked *